Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.610
+0.060 (3.87%)
Sep 9, 2025, 4:00 PM - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $456.71 million as of September 10, 2025. Its market cap has decreased by -43.05% in one year.
Market Cap
456.71M
Enterprise Value
119.38M
1-Year Change
-43.05%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $456.71M, a decrease of -75.42%. That is a compound annual growth rate of -28.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 439.69M | -38.04% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |